-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
What Is Going on With Lava Therapeutics (LVTX) Stock Today?
What Is Going on With Lava Therapeutics (LVTX) Stock Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Lava Therapeutics (NASDAQ:LVTX) stock is rocketing higher on Monday as investors react to news of an exclusive global license agreement with Seagen(NASDAQ:SGEN).
This agreement has Seagen agreeing to develop, manufacture and commercialize LAVA-1223. This is an advanced preclinical asset that makes use of Lava Therapeutics' proprietary Gammabody technology. This allows it to target epidermal growth factor receptor (EGFR)-expressing solid tumors.
That agreement has Seagen making an upfront payment of $50 million to Laval Therapeutics. It also includes up to $650 million in payments from development, regulatory and commercial milestones.
To go along with that, Seagen will also be paying Lava Therapeutics royalties on sales of the drug. The royalty rate ranges from single digits to the mid-teens.
LTVX's CEO Comments on the Agreement
Stephen Hurly, president and CEO of Lava Therapeutics, said the following about the deal.
"This agreement enables LAVA to further validate its platform in a second solid tumor product candidate, bringing us closer toward our goal of generating effective Gammabody medicines for cancer patients. We look forward to working with Seagen to develop potential next generation cancer treatments."
Today's news has shares of LVTX stock seeing heavy trading. As of this writing, over 23 million shares have changed hands. That's well above its daily average trading volume of only around 5,600 shares.
LVTX stock is up 100.1% as of Monday morning but is still down 22.1% year-to-date.
There's more stock market news traders will want to know about below!
We've got all of the latest stock market coverage investors need to know about on Monday! A few examples include the news moving shares of XPeng (NYSE:XPEV) and Bed Bath & Beyond (NASDAQ:BBBY) stock, as well as short squeeze targets for the week. You can get up to speed on all of that at the following links!
More Monday Stock Market News
- CEO He Xiaopeng Just Doubled Down on XPEV Stock. Here's Why.
- Dear BBBY Stock Fans, Mark Your Calendars for Sept. 29
- NERV, FAZE: The Top 5 Short Squeeze Stocks This Week
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post What Is Going on With Lava Therapeutics (LVTX) Stock Today? appeared first on InvestorPlace.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股票市場新聞、股票建議和交易提示
Lava Therapeutics (NASDAQ:LVTX) stock is rocketing higher on Monday as investors react to news of an exclusive global license agreement with Seagen(NASDAQ:SGEN).
熔岩治療學(納斯達克：LVTX)週一，隨著投資者對獨家全球許可協定的消息做出反應，股價飆升海洋發電公司(納斯達克：Sgen).
This agreement has Seagen agreeing to develop, manufacture and commercialize LAVA-1223. This is an advanced preclinical asset that makes use of Lava Therapeutics' proprietary Gammabody technology. This allows it to target epidermal growth factor receptor (EGFR)-expressing solid tumors.
根據這項協定，西根同意開發、製造和商業化熔岩-1223。這是一項先進的臨床前資產，利用了Lava治療公司的專有Gammabody技術。這使得它可以靶向表達表皮生長因數受體(EGFR)的實體腫瘤。
That agreement has Seagen making an upfront payment of $50 million to Laval Therapeutics. It also includes up to $650 million in payments from development, regulatory and commercial milestones.
根據該協定，西根向拉瓦爾治療公司預付了5000萬美元。它還包括來自開發、監管和商業里程碑的高達6.5億美元的付款。
To go along with that, Seagen will also be paying Lava Therapeutics royalties on sales of the drug. The royalty rate ranges from single digits to the mid-teens.
此外，Seagen還將支付Lava Treateutics銷售該藥物的特許權使用費。專利使用費的範圍從個位數到十幾歲左右。
LTVX's CEO Comments on the Agreement
LTVX首席執行官對該協定的評論
Stephen Hurly, president and CEO of Lava Therapeutics, said the following about the deal.
熔岩治療公司首席執行官兼首席執行官總裁對這筆交易說了以下幾句話。
"This agreement enables LAVA to further validate its platform in a second solid tumor product candidate, bringing us closer toward our goal of generating effective Gammabody medicines for cancer patients. We look forward to working with Seagen to develop potential next generation cancer treatments."
這項協定使LAVA能夠在第二種固體腫瘤候選產品中進一步驗證其平臺，使我們離為癌症患者生產有效的Gammabody藥物的目標更近了一步。我們期待著與Seagen合作開發潛在的下一代癌症治療方法。
Today's news has shares of LVTX stock seeing heavy trading. As of this writing, over 23 million shares have changed hands. That's well above its daily average trading volume of only around 5,600 shares.
今天的新聞讓LVTX的股票出現了大量的交易。截至撰寫本文時，已有2300多萬股易手。這遠高於其僅約5,600股的日均成交量。
LVTX stock is up 100.1% as of Monday morning but is still down 22.1% year-to-date.
截至週一上午，倫敦證交所的股價上漲了100.1%，但今年迄今仍下跌了22.1%。
There's more stock market news traders will want to know about below!
下面還有更多的股市消息交易員想知道的！
We've got all of the latest stock market coverage investors need to know about on Monday! A few examples include the news moving shares of XPeng (NYSE:XPEV) and Bed Bath & Beyond (NASDAQ:BBBY) stock, as well as short squeeze targets for the week. You can get up to speed on all of that at the following links!
我們已經掌握了投資者週一需要了解的所有最新股市報道！一些例子包括移動股票的消息小鵬汽車*(紐約證券交易所：XPEV)和床浴及更上一層樓(納斯達克：BBBY)股票，以及本週的空頭擠壓目標。你可以在下面的鏈接上獲得所有這些東西的最新進展！
More Monday Stock Market News
更多週一股市新聞
- CEO He Xiaopeng Just Doubled Down on XPEV Stock. Here's Why.
- Dear BBBY Stock Fans, Mark Your Calendars for Sept. 29
- NERV, FAZE: The Top 5 Short Squeeze Stocks This Week
- 首席執行官何小鵬剛剛在XPEV股票上加倍下注。這就是為什麼。
- 親愛的BBY股票粉絲們，在你們的日曆上標上9月1日的名字。29
- NERV，FUZE：本週五大做空股票
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版日期，威廉·懷特他沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點，以InvestorPlace.com為準。出版指南。
The post What Is Going on With Lava Therapeutics (LVTX) Stock Today? appeared first on InvestorPlace.
帖子今天Lava治療公司(LVTX)的股票怎麼了？最先出現在InvestorPlace上。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧